Lv41
430 积分 2025-11-23 加入
Efficacy and safety of aumolertinib/icotinib combination therapy for naive EGFR -mutant non–small-cell lung cancer patients with brain metastases: A phase I/II study
19天前
已完结
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
23天前
已完结
Circulating tumor DNA in early-stage NSCLC: prognostic value and challenges
4个月前
已完结
Minimal residual disease in colorectal cancer. Tumor-informed versus tumor-agnostic approaches: unraveling the optimal strategy
4个月前
已完结
Liquid biopsy: Comprehensive overview of circulating tumor DNA (Review)
4个月前
已完结
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
5个月前
已完结
P3.13.34 Tarlatamab Efficacy and Safety in Chinese Patients with Advanced Small Cell Lung Cancer: Phase 2 DeLLphi-307
5个月前
已关闭
皖公网安备34019202002308
